Pediatric Therapeutics and Pharmacology

Antibiotic-induced dilation of the ductus arteriosus: mechanisms and implications for ductus closure and postnatal reopening

Application of Pharmacogenomic Testing in Pediatric Kidney Transplant Patients

Development of an Immortalized Ductus Arteriosus (DA) Smooth Muscle Cell (SMC) Platform for High Throughput Drug Screening to Identify Novel Therapeutics for PDA

Exposure to opioids and benzodiazepines in preterm infants with and without major operative procedures

Furosemide pharmacokinetics in infants with established bronchopulmonary dysplasia using whole blood microsampling

Identification of priority medications for characterizing developmental changes in drug disposition after extremely preterm birth

Impact of Pharmacist-Driven Vancomycin Dosing Utilizing Area Under the Curve (AUC) Software in a Neonatal Intensive Care Unit (NICU)

Off-Label but On the Rise: National Trends of Clonidine Use in U.S. NICUs, 2008–2022

Pediatric Therapeutics and Pharmacology

Physiologically Based Pharmacokinetic Modeling of Intravenous Anakinra Exposure in Children

SAFE-KIDS: Study of Accuracy and Frequency of Errors in Kids’ Dosing in Acute Care Settings

Ultra-low dose ketamine is safe and effective at reducing pain intensity and total opioid requirement in pediatric patients

Using Reverse Image Search and Artificial Intelligence Technology to Identify Prescription Pills

Variation in dexamethasone prescribing practices for pediatric asthma exacerbations in acute care settings